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In order to control the cellular homeostasis and survival, the newly synthesized proteins 
are directed to Protein Quality Control system (PQC) to ensure the correct folding. PQC 
requires the coordinated action of molecular chaperones and proteolytic systems, the ubiq-
uitin–proteasome system (UPS) and the autophago-lysosomal pathway (ALP). Although 
the PQC system efficiently remove all the intracellular proteins, some misfolded proteins 
might escape from PQC defence. The accumulation of misfolded and aggregated proteins 
is a common hallmark of several motoneuron diseases (MNDs), including spinal bulbar 
muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS). SBMA is caused by a 
polyglutamine-expanded tract (polyQ) in the androgen receptor protein (AR). The binding 
of the ligand testosterone to the ARpolyQ induces protein misfolding and aggregation. The 
expanded polyQ tract confers to mutant AR a toxic gain-of-function that alters a cascade 
of several downstream pathways, including the PQC.
Using SBMA cellular and knock-in mice models, we observed that insufficient or impaired 
PQC activity contribute to ARpolyQ accumulation. In particular, ALP plays a crucial role in 
the clearance of ARpolyQ. We studied the activity of HSPB8-BAG3 complex, which acting 
with Hsc70 and CHIP, can direct ARpolyQ to ALP-mediated clearance. Analysing the ex-
pression of these genes in muscle of symptomatic SBMA mice, we found that HSPB8-PQC 
machinery is highly increased suggesting that ALP might be the preferential degradative 
pathway rather than UPS.
In this line, we analysed compounds able to activate or potentiate the HSPB8 machinery 
and ALP, in SBMA cell model. We have already tested the disaccharide trehalose, an m-
TOR independent ALP inducer. Even the mechanism of action of trehalose is still unclear, 
we demonstrate that it is able removed the ARpolyQ misfolding also via induction of HSPB8 
expression. However, the enzyme trehalase digest trehalose into glucose, reducing its bio-
availability. Therefore, we used two trehalase-indigestible dysaccharides, lactulose and 
melibiose. We found that lactulose and melibiose counteract ARpolyQ aggregation with 
effects comparable to trehalose. Recently, we also tested another interesting compound 
Berberine, a traditional herbal medicine. Berberine reduced the ARpolyQ aggregates facili-
tating the clearance of the mutant proteins activating the PQC system.
These data suggest that the autophagy/PQC inducers might have therapeutic potential for 
SBMA and other misfolding-related MNDs.
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